Ivabradine in combination with beta-blocker therapy for the treatment of stable angina pectoris in every day clinical practice

被引:0
作者
Ralf Koester
Jan Kaehler
Henning Ebelt
Gerold Soeffker
Karl Werdan
Thomas Meinertz
机构
[1] University Heart Center Hamburg,Clinic for General and Interventional Cardiology
[2] University Hospital Halle (Saale),Clinic for Internal Medicine III
[3] University Medical Center Hamburg-Eppendorf,Department of Intensive Care Medicine, Center for Anaesthesiology and Intensive Care Medicine
来源
Clinical Research in Cardiology | 2010年 / 99卷
关键词
Ivabradine; Coronary artery disease; Angina pectoris;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:665 / 672
页数:7
相关论文
共 144 条
[1]  
McLenachan JM(1991)Relations between heart rate, ischemia, and drug therapy during daily life in patients with coronary artery disease Circulation 83 1263-1270
[2]  
Weidinger FF(2007)The role of heart rate and the benefits of heart rate reduction in acute myocardial ischemia Eur Heart J 9 F8-F14
[3]  
Barry J(2009)Association of exercise capacity and the heart rate profile during exercise stress testing with subclinical coronary atherosclerosis: data from the Heinz Nixdorf Recall Study Clin Res Cardiol 98 665-676
[4]  
Yeung A(2006)Guidelines on the management of stable angina pectoris Eur Heart J 27 1341-1381
[5]  
Nabel EG(2007)Chronic Angina Focused Update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina Circulation 116 2762-2772
[6]  
Rocco MB(1987)Heart rate and cardiovascular mortality: the Framingham Study Am Heart J 113 1489-1494
[7]  
Selwyn AP(2007)Heart rate as an independent risk factor for cardiovascular disease. Current evidence and basic mechanisms Drugs 67 3-13
[8]  
Heusch G(2007)Resting heart rate in cardiovascular disease J Am Coll Cardiol 50 823-830
[9]  
Schulz R(2008)Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial Lancet 372 817-821
[10]  
Möhlenkamp S(2008)Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial Lancet 372 807-816